1 / 25

Management Strategies for Acute Promyelocytic Leukemia Complications

Explore a case of a 62-year-old man with APL presenting with chest pain and SOB, and delve into differential diagnosis, treatment options, and the critical aspect of identifying and reporting TRALI to the blood bank promptly.

cgoss
Download Presentation

Management Strategies for Acute Promyelocytic Leukemia Complications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. American College of Physicians Kansas Chapter Conference October 3, 2013 Ky Stoltzfus, MD University of Kansas Medical Center

  2. Have I got a case for you... Or should it be: Have I got a case for you?

  3. 62 year old man with acute promyelocytic leukemia • presents with shortness of breath and chest pain.

  4. HPI: • Chest pain over left sternum, dull, 7/10 severity, constant, began 4-5 hours prior, not relieved or worsened by any factors. • Associated SOB, started at same time, some cough and white sputum. Can't lay flat easily, gets “winded” with walking.

  5. Recent diagnosis of APL • Bone marrow hypercellular 95% with 80% blast or promyelocytes • Started All-Trans Retinoic Acid (ATRA) therapy the day of admission

  6. During visit he was noted to have • WBC 0.7 K/uL • Hgb 7.5 g/dL • Platelets 13 K/uL • Transfused 1 unit platelets

  7. ROS Positive for the following, otherwise negative: • Gen: fatigue, malaise, anorexia • CV: chest pain • Pulm: SOB, cough, sputum production • Neuro: dizziness

  8. PMH • HTN • CAD • Type II DM • Atrial fibrillation PSH • None

  9. Meds • tretinoin • flecainide • simvastatin • zolpidem • fish oil /omega-3 fatty acids • atenolol • polyethylene glycol (MIRALAX) • pantoprazole

  10. Soc Hx • Married • Nonsmoker, no EtOH, no illicit drugs Fam Hx • Father – prostate CA, died 82yo • Mother – CAD, HTN, living 84yo • Siblings – healthy • No other cancer history

  11. Physical Exam • 38.1C P99 R21 BP110/78 O2 87%RA • Gen: Sitting, in moderate respiratory distress, alert, oriented x 3 • Neck: No carotid bruits, no JVD • CV: Irregular, no S3 or S4, no murmur • Pulm: Crackles in bilateral bases and mid-lung fields • Abd: Soft, nontender, nondistended • Extrem: no cyanosis or edema • Pulses: 1+ bilateral radial, dorsalis pedal, posterior tibialis

  12. EKG: atrial fibrillation, rate 99, LVH, no ST or T wave changes, no Q waves

  13. Labs: Hgb 7.5, WBC 0.8, Plat 27 32%N, 3%Band, 30L, 4M, 31% blasts Na 131, Cl 101, bicarb 22, lactate 2.1, Cr 1.4, Tbili 1.5, LDH 299 Trop 0.01, BNP 185

  14. What's in your differential diagnosis? Here's mine: • CHF exacerbation • Transfusion Associated Cardiac Overload (TACO) • PNA, atypical • TRALI (Transfusion Associated Acute Lung Injury) • PE

  15. What would you do next? • Diurese patient • Possible emperic antibiotics • Consider CT chest or VQ scan • Contact your blood bank

  16. TRALI American Society of Hematology Education Program http://asheducationbook.hematologylibrary.org/content/2006/1/497.full

  17. TRALI • TRALI is characterized by acute non-cardiogenic pulmonary edema and respiratory compromise in the setting of transfusion • Normal CVP and wedge pressure • Mimics ARDS

  18. TRALI attributed to donor leukocyte antibodies. Alternate mechanism: “two hit” or “neutrophil priming” hypothesis.

  19. Incidence 1:432 whole blood platelets 1:557,000 red cells Plasma transmission variable (depends on region of the country)

  20. Testing HLA class I or class II, or neutrophil-specific antibodies in donor plasma and the presence of the cognate (corresponding) antigen on recipient neutrophils. Takes weeks to obtain this. TRALI is still a clinical diagnosis.

  21. Follow up Extremely important to notify your blood bank if TRALI is suspected. Donors can tracked. FDA is notified.

  22. Case continued Patient had worsened respiratory failure and subsequent multi-organ failure. He died in ICU on maximal life support.

  23. Summary Suspect TRALI if respiratory symptoms follow transfusion. Keep your differential diagnosis broad. Report suspected cases of TRALI to blood bank immediately.

More Related